Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Get more Watchlists, Portfolios, Custom Views and Chart Templates with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Exscientia Ltd ADR (EXAI)

Exscientia Ltd ADR (EXAI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 632,927
  • Shares Outstanding, K 130,770
  • Annual Sales, $ 24,980 K
  • Annual Income, $ -181,560 K
  • EBIT $ -213 M
  • EBITDA $ -198 M
  • 60-Month Beta 0.83
  • Price/Sales 23.96
  • Price/Cash Flow N/A
  • Price/Book 1.76

Options Overview Details

View History
  • Implied Volatility 87.26% ( +9.53%)
  • Historical Volatility 66.98%
  • IV Percentile 42%
  • IV Rank 11.57%
  • IV High 478.95% on 10/10/24
  • IV Low 36.00% on 08/12/24
  • Put/Call Vol Ratio 0.08
  • Today's Volume 142
  • Volume Avg (30-Day) 171
  • Put/Call OI Ratio 0.37
  • Today's Open Interest 5,174
  • Open Int (30-Day) 4,886

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 4 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/24
See More
  • Average Estimate -0.13
  • Number of Estimates 1
  • High Estimate -0.13
  • Low Estimate -0.13
  • Prior Year -0.42
  • Growth Rate Est. (year over year) +69.05%

Price Performance

See More
Period Period Low Period High Performance
1-Month
4.45 +8.76%
on 11/18/24
6.49 -25.42%
on 11/11/24
-0.37 (-7.10%)
since 10/18/24
3-Month
4.45 +8.76%
on 11/18/24
6.49 -25.42%
on 11/11/24
-0.65 (-11.84%)
since 08/19/24
52-Week
3.80 +27.37%
on 08/05/24
7.91 -38.81%
on 02/12/24
-1.26 (-20.66%)
since 11/17/23

Most Recent Stories

More News
Inside the AI-Healthcare Boom: Breakthroughs in Diagnostics and Personalized Treatment

Issued on behalf of Avant Technologies Inc. VANCOUVER – USA News Group News Commentary – A recent World Economic Forum report highlights AI's potential to ease the strain on healthcare systems...

MSFT : 412.87 (-0.63%)
NVDA : 146.67 (+0.53%)
TWST : 41.66 (+1.34%)
AVAI : 0.5300 (+1.92%)
ABSI : 2.55 (-4.85%)
RXRX : 5.75 (-4.80%)
EXAI : 4.84 (+3.20%)
1 AI Biotech Stock That Just Scored a Major Milestone

Down over 85% from all-time highs, Recursion Pharmaceuticals is an AI-powered biotech company that aims to accelerate the drug discovery process.

BAYZF : 20.4600 (-0.85%)
RXRX : 5.75 (-4.80%)
EXAI : 4.84 (+3.20%)
SNY : 47.98 (+0.42%)
AI in Healthcare Set for Explosive Growth with Projections Hitting $613 Billion by 2034

Issued on behalf of Avant Technologies Inc. VANCOUVER – USA News Group – Health care is undergoing a tech revolution, with health systems increasingly leveraging artificial intelligence (AI)...

BLFY : 11.20 (+1.27%)
AVAI : 0.5300 (+1.92%)
GEHC : 82.00 (-3.42%)
RXRX : 5.75 (-4.80%)
EXAI : 4.84 (+3.20%)
AI Revolution in Healthcare Gains Momentum as FDA Prepares for Tech Boom

/CNW/ -- USA News Group – Health care is undergoing a tech revolution, with health systems increasingly leveraging artificial intelligence (AI) bots for...

BLFY : 11.20 (+1.27%)
AVAI : 0.5300 (+1.92%)
GEHC : 82.00 (-3.42%)
RXRX : 5.75 (-4.80%)
EXAI : 4.84 (+3.20%)
The Bull Thesis for Recursion Pharmaceuticals Stock Just Got Stronger. Here's Why.

Merging with a former rival will bolster its capabilities.

NVDA : 146.67 (+0.53%)
RXRX : 5.75 (-4.80%)
EXAI : 4.84 (+3.20%)
How A.I. Is Shaping the Future of U.S. Healthcare: Regulatory and Market Updates

EQNX::TICKER_START (OTCQB:AVAI),(NASDAQ:RXRX),(NASDAQ:EXAI),(NASDAQ:TWST),(NYSE:IQV) EQNX::TICKER_END

AVAI : 0.5300 (+1.92%)
RXRX : 5.75 (-4.80%)
EXAI : 4.84 (+3.20%)
TWST : 41.66 (+1.34%)
IQV : 197.60 (+1.66%)
How A.I. Is Shaping the Future of U.S. Healthcare: Regulatory and Market Updates

AVAI : 0.5300 (+1.92%)
RXRX : 5.75 (-4.80%)
EXAI : 4.84 (+3.20%)
TWST : 41.66 (+1.34%)
IQV : 197.60 (+1.66%)
Is Recursion Pharmaceuticals a Buy Ahead of Its Merger With Exscientia?

The leading company pioneering artificial intelligence (AI)-fueled drug discovery could get much bigger.

EXAI : 4.84 (+3.20%)
RXRX : 5.75 (-4.80%)
3 Small-Cap Stocks to Invest in AI Drug Development

As AI continues to reshape the drug development landscape, here are three promising small-cap biotech stocks worth considering now.

RXRX : 5.75 (-4.80%)
SDGR : 20.37 (+6.26%)
EXAI : 4.84 (+3.20%)
NVDA : 146.67 (+0.53%)
Looking for the Next Big Thing? Add This AI Biotech to Your Watch List Right Now

Exscientia has the potential to be a star collaborator and a profitable drug developer, too.

EXAI : 4.84 (+3.20%)

Business Summary

Exscientia plc is an AI-driven pharmatech company. It involved in discovering, designing and developing drugs. Exscientia plc is based in OXFORD, England.

See More

Key Turning Points

3rd Resistance Point 5.33
2nd Resistance Point 5.09
1st Resistance Point 4.97
Last Price 4.84
1st Support Level 4.60
2nd Support Level 4.36
3rd Support Level 4.24

See More

52-Week High 7.91
Fibonacci 61.8% 6.34
Fibonacci 50% 5.86
Fibonacci 38.2% 5.37
Last Price 4.84
52-Week Low 3.80

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar